We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement

Cancer Immunology – News and Features

News

Cleveland BioLabs Announces Potential Direct Anticancer Effect of CBLB502

CBLB502 has direct anticancer effect in several transplanted cancer models grown in mice and rats including colon and lung cancer, lymphoma and melanoma.
News

Stellar Biotechnologies Achieves Major Milestone

Company announces completion of preclinical toxicity and immunogenicity testing of Stellar KLH/IMG and Stellar Subunit KLH in rodent and non-rodent species.
News

NewLink Genetics to Present Phase 2 Data of its HyperAcute® Pancreas Immunotherapy

The data will be presented during a poster session at the ASCO 2011 Gastrointestinal Cancers Symposium in San Francisco, California.
News

Generex and RXi Pharmaceuticals Announce Positive Research Data Using RNAi Technology

The data from the collaboration explores the use of RXi's RNAi technology to develop proprietary vaccine formulations for active immunotherapy.
News

Immutep and GlaxoSmithKline Sign Licence Agreement for IMP731 for the Treatment of Autoimmune Diseases

The licence agreement grants GSK exclusive rights to depleting LAG-3 antibodies including ImmuTune IMP731.
News

Immutep and GlaxoSmithKline Sign Licence Agreement for a Novel Therapeutic Antibody for the Treatment of Autoimmune Diseases

Worldwide licence gives GSK exclusive rights to depleting LAG-3 antibodies including ImmuTune IMP731.
News

Quantum Immunologics Announces Appointment of Dr George Peoples to Scientific Advisory Board

Quantum Immunologics, Inc. announces the appointment of Dr George E. Peoples, M.D., of Brooke Army Medical Center, San Antonio, TX to QI's Scientific Advisory Board.
News

Myotec Merges with Hybrid Biosystems to Form PsiOxus Therapeutics

Imperial Innovations Group plc, a leading technology commercialisation and investment group, announces the merger of its portfolio company Myotec Therapeutics Ltd. (Myotec) with Hybrid Biosystems Ltd. (Hybrid) to form PsiOxus Therapeutics.
News

Roche and the Baylor Research Institute Partner in Human Immunology Research

Focus on cancer vaccines, auto-immune disease diagnostics and treatment.
News

MorphoSys and Xencor Initiate Phase 1 Study of Anti-CD19 Antibody in Chronic Lymphocytic Leukemia

The trial is designed to assess the drug's safety, tolerability, pharmacokinetic profile and preliminary anti-tumor activity in CLL patients.
Advertisement